№ files_lp_3_process_7_096097
File format: docx
Character count: 1865
File size: 21 KB
Individualized standing orders detailing the authorized procedures and supervision levels for EFDHA I certified personnel, including prophylaxis, sealants, and patient education in village-based dental practice.
Year:
Alaska Area
Document Type:
Certification Standing Orders
Organization:
Alaska Area Community Health Aide Program Certification Board
Certification Number:
EFDHA I _________________________________
Scope of Practice:
Dental prophylaxis, sealants, village-based dental services
Supervision Requirements:
Direct, Indirect, General as specified
Validity Period:
2 years or within 3 months of supervisor change
Signatories:
EFDHA I, Supervising Dentist, Dental Program Director
Target Audience:
Certified EFDHA I personnel
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2022
Region / City:
Cleveland County, Norman, Oklahoma
Subject:
Road Oils, Emulsions, and Sealants
Document Type:
Invitation to Bid
Organization / Institution:
Cleveland County Purchasing
Author:
Cleveland County Purchasing Department
Target Audience:
Bidders
Period of Validity:
September 7, 2022 - March 6, 2023
Approval Date:
7-27-22
Amendment Date:
8-5-22
Year:
2023
Region / City:
Cleveland County, Norman, Oklahoma
Subject:
Bid Invitation for Road Oils, Emulsions, and Sealants
Document Type:
Invitation to Bid
Organization:
Cleveland County Purchasing
Author:
Cleveland County Purchasing
Target Audience:
Vendors and Bidders
Validity Period:
From September 7, 2023, to March 6, 2024
Approval Date:
08/09/2023
Amendment Date:
08/09/2023
Year:
2025
Region / City:
Cleveland County, Norman, Oklahoma
Subject:
Road oils, emulsions, and sealants supply
Document Type:
Invitation to Bid
Agency / Organization:
Cleveland County Purchasing
Author:
Cleveland County Purchasing
Target Audience:
Bidders, contractors
Effective Period:
September 7, 2025 - March 6, 2026
Approval Date:
08/12/2025
Amendment Date:
08/12/2025
Year:
2022
Region / City:
Cleveland County, Norman, Oklahoma
Subject:
Road Oils, Emulsions, Sealants
Document Type:
Invitation to Bid
Organization:
Cleveland County Purchasing
Author:
Cleveland County Purchasing Department
Target Audience:
Bidders
Period of Effect:
March 7, 2022 – September 6, 2022
Approval Date:
1-26-22
Modification Date:
2-2-22
Description:
Invitation to submit sealed bids for a six-month contract for road oils, emulsions, and sealants for Cleveland County.
Year:
2025
Region / City:
Cleveland County, Norman, Oklahoma
Topic:
Procurement / Contracting
Document Type:
Invitation to Bid
Organization / Institution:
Cleveland County Purchasing
Author:
Cleveland County Purchasing
Target Audience:
Bidders interested in supplying road oils, emulsions, and sealants
Period of Action:
March 7, 2025 through September 6, 2025
Approval Date:
02/05/2025
Amendment Date:
02/05/2025
Year:
2025
Region / City:
Cleveland County, Norman, Oklahoma
Subject:
Invitation to Bid
Document Type:
Contract Solicitation
Organization / Institution:
Cleveland County Purchasing
Author:
Cleveland County
Target Audience:
Suppliers and Contractors
Effective Period:
March 7, 2025 - September 6, 2025
Approval Date:
03/11/2025
Amendment Date:
03/20/2025
Organization:
Canberra Health Services
Type of document:
Clinical guideline
Topic:
Dental fissure sealants and fissure protection
Population:
Children and adolescents
Target audience:
Dental practitioners
Region:
Australia
Healthcare sector:
Oral health services
Clinical focus:
Caries prevention and early intervention
Materials covered:
Resin-based sealants; glass ionomer cement sealants
Scope of application:
Public oral health services
Evidence base:
Research studies and professional guidelines
Includes procedures:
Yes
Includes risk assessment:
Yes
Includes attachments:
Yes
Year:
2014
Region / City:
Beachwood, OH
Topic:
Waterproofing, Construction Materials
Document Type:
Guide Specification
Organization:
Tremco, Inc.
Author:
Tremco, Inc.
Target Audience:
Architects, Specifiers, Contractors
Duration:
Not specified
Approval Date:
Not specified
Revision Date:
Not specified
Year:
2024
Region / City:
Cleveland County, Norman, Oklahoma
Topic:
Procurement
Document Type:
Invitation to Bid
Agency:
Cleveland County Purchasing
Author:
Cleveland County Purchasing Department
Target Audience:
Bidders, Contractors
Effective Period:
March 7, 2024 - September 6, 2024
Approval Date:
01/24/2024
Amendment Date:
Not specified
Topic:
Preventive dentistry
Document type:
Informational educational text
Subject:
Dental sealants for children and adolescents
Geographic context:
United States
Organizations mentioned:
American Dental Association; National Institute of Dental Research; American Public Health Association
Target audience:
Parents and caregivers of children; dental patients
Medical focus:
Prevention of tooth decay on occlusal surfaces
Recommended age period:
First 5 to 14 years after tooth eruption
Application performed by:
Dentist or dental assistant
Materials described:
Plastic sealant coating; fluoride products
Note:
Year
Year:
2024
Region / City:
Global
Topic:
HIV Prevention, Post-exposure Prophylaxis
Document Type:
Guidelines
Organization / Institution:
MOSAIC, USAID, The Global Fund
Author:
MOSAIC Project
Target Audience:
Policymakers, Healthcare Providers
Period of Effectiveness:
Not specified
Approval Date:
December 2024
Date of Modifications:
Not specified
Contextual description:
Adaptable guidelines for developing and adopting national post-exposure prophylaxis protocols aligned with WHO recommendations, aimed at improving access and effectiveness of HIV prevention strategies.
Year:
2025
Region / City:
United Kingdom
Subject:
Influenza prophylaxis
Document Type:
Patient Group Direction (PGD)
Organisation:
UK Health Security Agency (UKHSA)
Author:
Shilan Ghafoor, Dr. Matthew Donati, Lesley McFarlane
Target Audience:
Healthcare practitioners
Effective Period:
08 August 2025 - 07 August 2028
Approval Date:
08 August 2025
Review Date:
08 August 2027
Expiry Date:
07 August 2028
Version:
6.0
Clinical Content Authorisation:
UKHSA
Amendments History:
See Change History
Relevant Legislation:
Human Medicines Regulations 2012 (HMR2012)
Context:
Document outlines a Patient Group Direction for the supply of oseltamivir for post-exposure prophylaxis of seasonal influenza for residents, users, and staff of care facilities in the UK, with specifications on authorisation, amendments, and use by healthcare practitioners.
Year:
2024
Region / City:
Global
Topic:
HIV Prevention
Document Type:
Guidelines
Organization / Institution:
WHO, MOSAIC, USAID, The Global Fund to Fight AIDS, Tuberculosis and Malaria
Author:
MOSAIC, WHO, USAID
Target Audience:
Policymakers, health professionals
Period of Validity:
Ongoing
Approval Date:
October 2024
Date of Updates:
October 2024
Year:
2016
Region / city:
Oxford, Bristol, Nottingham, York
Theme:
Medical, Oncology
Document Type:
Guideline
Organization / institution:
John Radcliffe Hospital, Bristol Children’s Hospital, University of York
Author:
Rebecca Proudfoot, John Radcliffe Hospital, Rachel Cox, Bristol Children’s Hospital, Bob Phillips, University of York, Sophie Wilne, University Hospitals Nottingham NHS Trust
Target audience:
Healthcare professionals involved in pediatric oncology
Period of validity:
Ongoing recommendations
Approval Date:
July 2016
Date of revisions:
Not mentioned
Context:
Clinical guideline for the prevention of Pneumocystis Jirovecii Pneumonia in children with solid tumors undergoing oncological treatments.
Author:
Dr. Mark Bishton, Honorary Consultant Haematologist, Nottingham University [email protected]
Version:
Draftv1.2
Ratified by & Date:
EM Haematology ECAG 03/10/2025
Review date:
October 2027
Explicit definition of patient group to which it applies:
Patients with Lymphoma receiving steroid containing chemotherapy regimens
NICE guidance reference:
N/A
Note:
Summary of evidence base this guideline has been created from
Version No.:
1.0, 1.1, 1.2
Date:
March 2025, July, September
Revision Author:
M Bishton
Status:
Draft, FINAL
Description:
Updates on bisphosphonate use and recent ECAG review
Indication of prophylaxis:
Bisphosphonate prophylaxis for patients with at least 1 listed risk factor
Bisphosphonate agents:
Alendronic acid, Zolendronic acid, Risedronate, Denosumab
Adjunctive treatment:
Vitamin D supplementation required
Year:
2025
Region / City:
Massachusetts
Topic:
Lyme Disease, Postexposure Prophylaxis
Document Type:
Medical Guideline
Organization / Institution:
Massachusetts Department of Public Health
Author:
Massachusetts Department of Public Health
Target Audience:
Healthcare providers
Period of Effectiveness:
July 14, 2025
Approval Date:
July 14, 2025
Date of Changes:
N/A
Document type:
Clinical guideline appendix
Chapter:
8 Plastic Surgery
Appendix:
1
Subject:
Perioperative venous thromboembolism prophylaxis
Content:
Summary of the quality of studies
Focus:
Deep vein thrombosis (DVT) and pulmonary embolism (PE)
Population:
Patients undergoing plastic and reconstructive surgery
Interventions:
Chemoprophylaxis, mechanical prophylaxis, risk assessment models, anticoagulation strategies
Outcomes:
DVT incidence, VTE incidence, bleeding rate, free flap failure rate, mortality
Risk of bias assessment:
Low, Intermediate, High
Studies included:
Observational studies and comparative studies
Update status:
First update
Standard:
AABB 29th Standards 5.30
Thema:
Rh Immune Globulin prophylaxis
Dokumenttyp:
Transfusionsrichtlinie
Fachbereich:
Transfusionsmedizin
Betroffene Patientengruppe:
Rh negative Patientinnen und Patienten
Zielgruppe:
Schwangere Frauen und transfusionsmedizinische Dienste
Schwangerschaftszeitraum:
Pränatal, ≥20 Wochen Gestation, ≤20 Wochen Gestation, postpartal
Testverfahren:
ABO-Typisierung, Rh-Typisierung mit Weak D, Antikörpersuchtest, Fetalscreen Rosette-Test, Flow Cytometry Hemoglobin F, Kleihauer Betke Fetal Stain
Dosierung:
300 Mikrogramm Rh Immune Globulin pro Standarddosis
Berechnungsgrundlage:
Prozent fetaler Zellen × 50, Division durch 30 ml Vollblut pro Dosis
Indikation:
Exposition gegenüber Rh positiven Erythrozyten
Besondere Hinweise:
Fetalscreen nur gültig bei >20 Wochen und DAT negativem Neugeborenen
Year:
2024
Region / city:
Global
Theme:
HIV Prevention, Pre-exposure Prophylaxis (PrEP)
Document type:
Guideline
Organization:
WHO, USAID, Global Fund
Author:
MOSAIC, FHI 360
Target audience:
National policymakers, healthcare providers
Period of validity:
Ongoing
Approval date:
October 2024
Modification date:
October 2024